Breaks Categories: News

WednesdayMar 30, 2022 12:34 pm

NetworkNewsBreaks – Sugarmade Inc. (SGMD) Announces Expansion of Cannabis Delivery Business, New Distribution Model with Dining Partnership

Sugarmade (OTC: SGMD), an emerging leader in the vertically integrated cannabis marketplace based in California, has signed two definitive agreements designed to expand the company’s footprint. One of the agreements establishes SGMD’s majority ownership in a fully licensed new Hollywood cannabis delivery hub on Strip as well as a minority stake in an expanding reservation-only restaurant brand that offers a private event space that allows cannabis consumption. The announcement also noted that SGMD will have majority ownership in a brand-new cannabis retail distribution hub offering delivery in the affluent neighborhoods of the West Hollywood Hills. Sugarmade also inked a deal…

Continue Reading

WednesdayMar 30, 2022 12:03 pm

NetworkNewsBreaks – Flora Growth Corp.’s (NASDAQ: FLGC) CEO Slated to Present Keynote at Upcoming Plant Medicine Week Conference

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, will be participating in the Plant Medicine Week conference, which is scheduled to be held April 5–8, 2022, in Malta. Flora Growth chair and CEO Luis Merchan is the keynote speaker at the four-day event. Merchan’s presentation, titled “Malta — The Gateway to South American and European Cannabis Relations,'' is slated to start at 2:30 CET and will focus on the opportunity presented by Malta’s standpoint on cannabis as well as the cost advantages of South American cultivation and the broader European opportunity. The…

Continue Reading

WednesdayMar 30, 2022 11:53 am

NetworkNewsBreaks – Silo Pharma Inc. (SILO) Initiates Coverage with InvestorBrandNetwork

Silo Pharma (OTCQB: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, has partnered with InvestorBrandNetwork (“IBN”) for its corporate communications. IBN is a multifaceted financial news and publishing company focused on private and public entities. Silo works to develop innovative solutions that address serious conditions such as post-traumatic stress disorder (PTSD), fibromyalgia, Alzheimer’s disease, Parkinson’s disease and other rare neurological disorders. The company is committed to identifying and partnering with leading medical universities; SILO provides invaluable financial resources to develop safe therapeutic treatments while advancing research through clinical stage studies and trials and into…

Continue Reading

TuesdayMar 29, 2022 1:27 pm

NetworkNewsBreaks – FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) Names New Market Research Appointments

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF), a Canadian-based, growth-stage company committed to providing commercially viable and sustainable, cradle-to-cradle, clean-energy solutions, has announced two new appointments charged with fully understanding its customers as the company prepares to enter the market. According to the announcement, FuelPositive will be working with Pollara Strategic Insights as a market research partner and with Leith Deacon, an associate professor and researcher from the University of Guelph, as an advisor who assist in market research efforts. Founded in 1980, Pollara Strategic Insights is one of Canada’s premier full-service research firms. Deacon is a member of the Canadian Institute of…

Continue Reading

TuesdayMar 29, 2022 1:20 pm

NetworkNewsBreaks – reBLOCKmiami to Shine the Spotlight on Real Estate Blockchain and Timely Topics, Innovations in the Space

Cutting Edge Events, organizers of Florida Bitcoin & Blockchain Summit, Crypto Mondays and the UnOfficial Bitcoin Miami Kickoff Party, today announced reBLOCKmiami, a one-day real estate blockchain event hosted April 5 in Miami, known as the crypto capital of the world. The reBLOCKmiami event will feature timely topics in sessions and presentations, including Real Estate Blockchain, Real Estate Tokenization, Real Estate NFTs, Real Estate Liquidity DAOs, Regulatory Updates, DeFi Real Estate, Real Estate Fintech Startups, Tradeable Private Real Estate and Buying Property in the Metaverse. reBLOCKmiami is tailored to fit the needs of three types of attendees: Beginners looking to…

Continue Reading

TuesdayMar 29, 2022 1:16 pm

NetworkNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Continues Market Expansion with Silicon Valley Deployment

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, has deployed another of its proprietary K5 Autonomous Security Robots (“ASRs”) in California. The white and red K5 ASR is patrolling a Silicon Valley commercial real estate (“CRE”) twin-tower office complex. The company noted that today’s CRE tenants are looking for the latest security when they sign a lease package. Commercial property managers need security strategies designed to provide protection against the unique nature of today’s threats while still providing convenience and flexibility; Knightscope shines in offering solutions to these demands. The company’s smarter security…

Continue Reading

TuesdayMar 29, 2022 1:09 pm

NetworkNewsBreaks – ECGI Holdings Inc. (ECGI) Approaches Key Strategic Moves in Legal Cannabis and Cannabinoid Marketplace

ECGI Holdings (OTC: ECGI) (d.b.a. Elite Cannabis Group Incorporated), a Nevada-based portfolio company pivoting into the legal cannabis and cannabinoid marketplace, today provided current and prospective shareholders with an update on the company’s operations. “We are working to finalize a transaction to acquire key assets that will serve the purpose of granting us our Major Use License for the upcoming year so we can start our cultivation operations in full,” said William Chung, CEO of ECGI Holdings. Beyond that strategic move, the company is working toward several key acquisitions of intellectual property, talent and tangible operating assets within the cannabinoid…

Continue Reading

TuesdayMar 29, 2022 1:03 pm

NetworkNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Schedules Call to Review Q1, Full-Year Report

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS (“SaaS”) platform, has announced an upcoming conference call to discuss its full year and fourth quarter 2021 results; the call is scheduled for Monday, April 4, 2022, at 4:30 p.m. ET. SRAX founder and CEO Christopher Miglino will be joined with SRAX chief financial officer Michael Malone during the call; the pair will provide a summary of  its fourth-quarter and full-year 2021 report. The call will also include a question-and-answer session. Interested individuals can dial 346-248-7799 then use meeting ID 92478894626…

Continue Reading

TuesdayMar 29, 2022 12:32 pm

NetworkNewsBreaks – InnerScope Hearing Technologies Inc. (INND) Launches HearingAssist Products on RiteAid.com

InnerScope Hearing Technologies (OTC: INND), an emerging and disruptive leader in the direct-to-consumer hearing technology space, today announced that its subsidiary HearingAssist has launched its branded hearing products and related supplies on RiteAid.com. According to the announcement, the initial launch includes HearingAssist’s hearing aid care and assorted hearing aid batteries, earwax removal ear spray, as well as a wireless neckband TV listener hearing amplifier. “The management teams of HearingAssist and InnerScope are proud to offer HearingAssist products for all Rite Aid customers,” said Matthew Moore, president and CEO of InnerScope Hearing Technologies. “The launch of HearingAssist products on RiteAid.com increases…

Continue Reading

TuesdayMar 29, 2022 12:17 pm

NetworkNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces Significant Milestone Toward Advancing CYB003 Program

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” today announced the completion of in vivo preclinical studies evaluating its deuterated psilocybin analog CYB003 for the potential treatment of major depressive disorder (“MDD”). According to the update, data from the studies demonstrate that CYB003 is well-tolerated following several doses in multiple species and support the advancement toward an investigational new drug (“IND”) filing with the U.S. Food and Drug Administration (“FDA”) for a Phase 1/2a first-in-human clinical trial in patients with MDD. “The completion of these in vivo preclinical studies for CYB003 represents a…

Continue Reading